The Effects of Decreasing the Lasix Dose on the Cardiorenal System
Completed · Phase 1/Phase 2
Conditions studied: Heart Failure, Kidney Dysfunction
In brief
The investigators' objective is to define the effects of decreasing the furosemide dose on heart, kidney and humoral function in people with compensated heart failure and kidney dysfunction and also in people with compensated heart failure without kidney dysfunction. Secondly, to define the humoral activation in both groups.
Key facts
- Study ID
- NCT00982423
- Run by
- Mayo Clinic
- People needed
- 41
- Starts
- 2009-07-01
- Expected to finish
- 2014-07-01
- Last updated by the study team
- 2015-07-20
Who can join
Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.